The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Comparative analysis of outcomes in African American (AA) and white (W) patients (pts) with multiple myeloma (MM) treated with lenalidomide (LEN) or pomalidomide (POM).
 
Sikander Ailawadhi
Consulting or Advisory Role - Amgen; Celgene; Novartis; Takeda
Research Funding - Pharmacyclics (Inst)
Travel, Accommodations, Expenses - Amgen; Novartis; Takeda
 
Philip L. McCarthy
Honoraria - Binding Site; Bristol-Myers Squibb; Celgene; Sanofi/Aventis; Takeda
Research Funding - Celgene
Other Relationship - Binding Site; Bristol-Myers Squibb; Celgene; Karyopharm Therapeutics; Sanofi/Aventis; Takeda
 
Sarah A. Holstein
Consulting or Advisory Role - Celgene; Takeda
Travel, Accommodations, Expenses - Celgene
 
Gail Larkins
Employment - Celgene
 
Weiyuan Chung
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Shankar Srinivasan
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Patents, Royalties, Other Intellectual Property - Patent on a Graphic tool with applications including the characterization of the use of oncology therapies over time. US patent 7,495,673 B1.; Patent pending on a heat map prediction matrix tool in Multiple Myeloma predicting survival. (Inst)
 
Amit Agarwal
Employment - Celgene
 
Sagar Lonial
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Millennium; Novartis; Onyx